BioInfra Life Science (XKON:A266470) - Stock Price, News & Analysis

A266470 Stock Overview

A266470 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₩3B)

Highly volatile share price over the past 3 months compared to the KR market

BioInfra Life Science Inc. Competitors

TechnologyLtd

KOSDAQ:A043090

₩22.2b

Celemics

KOSDAQ:A331920

₩28.6b

WOOJUNG BIO

KOSDAQ:A215380

₩32.3b

Green Lifescience

KOSDAQ:A114450

₩35.4b

Price History & Performance

Summary of all time highs, changes and price drops for BioInfra Life Science
Historical stock prices
Current Share Price	₩240.00
52 Week High	₩580.00
52 Week Low	₩196.00
Beta	0
11 Month Change	-21.82%
3 Month Change	-29.41%
1 Year Change	-43.53%
33 Year Change	-90.93%
5 Year Change	n/a
Change since IPO	-94.08%

Recent updates

Shareholder Returns

	A266470	KR Life Sciences	KR Market
7D	12.7%	-9.0%	-2.8%
1Y	-43.5%	33.1%	-3.4%

Return vs Industry: A266470 underperformed the KR Life Sciences industry which returned 33.1% over the past year.

Return vs Market: A266470 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A266470's price volatile compared to industry and market?
A266470 volatility
A266470 Average Weekly Movement	15.7%
Life Sciences Industry Average Movement	8.8%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A266470's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A266470's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Dukyun Lee	www.bioinfra.co.kr

BIOINFRA Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea. Its portfolio includes cancer screening test technology, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment. The company was founded in 2001 and is based in Seoul, South Korea.

BioInfra Life Science Inc. Fundamentals Summary

How do BioInfra Life Science's earnings and revenue compare to its market cap?
A266470 fundamental statistics
Market cap	₩3.38b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A266470 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A266470 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A266470 perform over the long term?

See historical performance and comparison

BioInfra Life Science XKON:A266470 Stock Report